BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Neuropathy (all types) |
📓
Distinctive Microbial Signatures and Gut-Brain Crosstalk in Pediatric Patients with Coeliac Disease and Type 1 Diabetes Mellitus. International journal of molecular sciences (Int J Mol Sci ) Vol: 22 Issue 4 Pages: Pub: 2021 Feb 3 Epub: 2021 Feb 3 Authors Singh P , Rawat A , Al-Jarrah B , Saraswathi S , Gad H , Elawad M , Hussain K , Hendaus MA , Al-Masri W , A Malik R , Al Khodor S , Akobeng AK , Html Article Publication |
| Neuropathy (all types) |
📓
Metabolomics and Gut Microbiota in Elderly Patients with Diabetic Peripheral Neuropathy and Sarcopenia. Diabetes, metabolic syndrome and obesity : targets and therapy (Diabetes Metab Syndr Obes ) Vol: 18 Issue Pages: 4335-4345 Pub: 2025 Epub: 2025 Nov 22 Authors Wang X , Yu F , Cai Q , Li B , Li X , Fu C , Yu X , Yin W , Zeng S , Gao H , Cheng M , Html Article Publication |
| Neuropathy (all types) |
📓
Changes of intestinal microbiome and its relationship with painful diabetic neuropathy in rats. BMC microbiology (BMC Microbiol ) Vol: 25 Issue 1 Pages: 281 Pub: 2025 May 8 Epub: 2025 May 8 Authors Jia S , Mi H , Su Y , Liu Y , Ming Z , Lin J , Html Article Publication |
| Neuropathy (all types) |
📓
Gut dysbiosis in patients with chronic pain: a systematic review and meta-analysis. Frontiers in immunology (Front Immunol ) Vol: 15 Issue Pages: 1342833 Pub: 2024 Epub: 2024 Jan 30 Authors Goudman L , Demuyser T , Pilitsis JG , Billot M , Roulaud M , Rigoard P , Moens M , Html Article Publication |
| Neuropathy (all types) |
📓
Alterations in the gut microbiota and metabolite profiles in the context of neuropathic pain. Molecular brain (Mol Brain ) Vol: 14 Issue 1 Pages: 50 Pub: 2021 Mar 9 Epub: 2021 Mar 9 Authors Chen P , Wang C , Ren YN , Ye ZJ , Jiang C , Wu ZB , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
